Literature DB >> 719630

Fecal profiles of anaerobic microflora of large bowel cancer patients and patients with nonhereditary large bowel polyps.

A J Mastromarino, B S Reddy, E L Wynder.   

Abstract

It has been postulated that the intestinal anaerobes play a role in the etiology of large bowel cancer. This study was designed to characterize and compare the fecal anaerobes of patients with large bowel cancer, patients with nonhereditary large bowel polyps, and healthy control subjects. Although some distributional variations of the anaerobic genera were observed among the study groups, significant differences in fecal anaerobic microflora and total aerobic counts were not noted. This suggests that taxonomic grouping of fecal bacteria is an inadequate measure of relative risk of developing large bowel cancer. However, the fecal microbial 7alpha-dehydroxylase and cholesterol dehydrogenase activities of large bowel cancer patients and patients with nonhereditary large bowel polyps were significantly higher than those of healthy control subjects. On the other hand, no significant difference in fecal microbial beta-glucuronidase activity was noted among the study groups. It may be that assessment of the total metabolic activities of the intestinal microflora will provide a better understanding of their potential role in the genesis of large bowel cancer.

Entities:  

Mesh:

Year:  1978        PMID: 719630

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Effect of polyethylene glycol-electrolyte lavage solution on intestinal microflora.

Authors:  M Morotomi; J G Guillem; J Pocsidio; P LoGerfo; M Treat; K A Forde; I B Weinstein; I Watanabe; M Mutai
Journal:  Appl Environ Microbiol       Date:  1989-04       Impact factor: 4.792

2.  Analysis of bile acids in colon residual liquid or fecal material in patients with colorectal neoplasia and control subjects.

Authors:  T Kishida; F Taguchi; L Feng; A Tatsuguchi; J Sato; S Fujimori; H Tachikawa; Y Tamagawa; Y Yoshida; M Kobayashi
Journal:  J Gastroenterol       Date:  1997-06       Impact factor: 7.527

Review 3.  Enterocyte proliferation and intracellular bacteria in animals.

Authors:  S McOrist; C J Gebhart; G H Lawson
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

Review 4.  The role of dietary fibre in the human colon.

Authors:  J H Cummings; A M Stephen
Journal:  Can Med Assoc J       Date:  1980-12-06       Impact factor: 8.262

5.  Fermentation by the human large intestine microbial community in an in vitro semicontinuous culture system.

Authors:  T L Miller; M J Wolin
Journal:  Appl Environ Microbiol       Date:  1981-09       Impact factor: 4.792

6.  Conversion of amoscanate to a mutagenic metabolite in gnotobiotic mice implanted with Streptococcus equinus.

Authors:  B S Reddy; R P Batzinger; C J Molineaux; E Bueding
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

7.  Comparison of fecal microflora of elderly persons in rural and urban areas of Japan.

Authors:  Y Benno; K Endo; T Mizutani; Y Namba; T Komori; T Mitsuoka
Journal:  Appl Environ Microbiol       Date:  1989-05       Impact factor: 4.792

8.  Effect of long term lactulose ingestion on secondary bile salt metabolism in man: potential protective effect of lactulose in colonic carcinogenesis.

Authors:  G P van Berge Henegouwen; S D van der Werf; A T Ruben
Journal:  Gut       Date:  1987-06       Impact factor: 23.059

9.  Unconjugated secondary bile acids in the serum of patients with colorectal adenomas.

Authors:  E Bayerdörffer; G A Mannes; T Ochsenkühn; P Dirschedl; B Wiebecke; G Paumgartner
Journal:  Gut       Date:  1995-02       Impact factor: 23.059

10.  Deoxycholate induces COX-2 expression via Erk1/2-, p38-MAPK and AP-1-dependent mechanisms in esophageal cancer cells.

Authors:  Eileen Looby; Mohamed M M Abdel-Latif; Veronica Athié-Morales; Shane Duggan; Aideen Long; Dermot Kelleher
Journal:  BMC Cancer       Date:  2009-06-17       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.